AKT1 and ovarian carcinoma: The study of Gider et al has suggested that miR-142-3p is highly expressed in the peripheral blood samples of ovarian cancer patients, which may be used as the biomarker for the diagnosis, treatment and prognosis of ovarian cancer.[7] Gao et al[8] has revealed that miR-142-3p promotes the invasive ability of colorectal cancer cells by activating Rac family small GTPase 1.